These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27717650)

  • 21. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
    Chen YC; Kuo SF; Chen FJ; Lee CH
    Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole.
    Hsueh PR; Teng LJ; Yang PC; Ho SW; Luh KT
    Microb Drug Resist; 2002; 8(4):311-9. PubMed ID: 12523628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.
    Pfaller MA; Jones RN; Doern GV; Sader HS; Hollis RJ; Messer SA
    J Clin Microbiol; 1998 Jul; 36(7):1886-9. PubMed ID: 9650930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients.
    Hrabovský V; Takáčová V; Schréterová E; Pastvová L; Hrabovská Z; Čurová K; Siegfried L
    Folia Microbiol (Praha); 2017 Nov; 62(6):525-530. PubMed ID: 28361459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
    Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National surveillance of antifungal susceptibility of Candida species in South Korean hospitals.
    Yoo JI; Choi CW; Lee KM; Kim YK; Kim TU; Kim EC; Joo SI; Yun SH; Lee YS; Kim BS
    Med Mycol; 2009; 47(5):554-8. PubMed ID: 18819023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
    Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
    J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution and drug susceptibilities of Candida species causing candidemia from a medical center in central Taiwan.
    Chang TP; Ho MW; Yang YL; Lo PC; Lin PS; Wang AH; Lo HJ
    J Infect Chemother; 2013 Dec; 19(6):1065-71. PubMed ID: 23732308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea.
    Jung SI; Shin JH; Song JH; Peck KR; Lee K; Kim MN; Chang HH; Moon CS;
    Med Mycol; 2010 Jun; 48(4):669-74. PubMed ID: 20392145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia.
    Amran F; Aziz MN; Ibrahim HM; Atiqah NH; Parameswari S; Hafiza MR; Ifwat M
    J Med Microbiol; 2011 Sep; 60(Pt 9):1312-1316. PubMed ID: 21459913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals.
    Tan TY; Tan AL; Tee NW; Ng LS
    Ann Acad Med Singap; 2008 Oct; 37(10):835-40. PubMed ID: 19037517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.
    Tan TY; Tan AL; Tee NW; Ng LS; Chee CW
    Mycoses; 2010 Nov; 53(6):515-21. PubMed ID: 19619263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
    Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten-year study of species distribution and antifungal susceptibilities of Candida bloodstream isolates at a Brazilian tertiary hospital.
    Bonfietti LX; Szeszs MW; Chang MR; Martins MA; Pukinskas SR; Nunes MO; Pereira GH; Paniago AM; Purisco SU; Melhem MS
    Mycopathologia; 2012 Dec; 174(5-6):389-96. PubMed ID: 22821345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Species distribution and antifungal susceptibility of blood Candida isolates at a tertiary hospital in southern Taiwan, 1999-2006.
    Chen PL; Lo HJ; Wu CJ; Lee HC; Chang CM; Lee NY; Wang AH; Lin WL; Ko NY; Lee CC; Ko WC
    Mycoses; 2011 Jul; 54(4):e17-23. PubMed ID: 20028463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan.
    Yang YL; Cheng HH; Ho YA; Hsiao CF; Lo HJ
    J Microbiol Immunol Infect; 2003 Sep; 36(3):187-91. PubMed ID: 14582563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Species distribution and antifungal susceptibility of Candida spp. causing superficial mycosis. Coro, Falcon state, Venezuela].
    Saúl-García Y; Humbría-García L; Hernández-Valles R
    Invest Clin; 2015 Sep; 56(3):276-83. PubMed ID: 26710542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.